#372 Breaking Barriers in Psychedelic Drug Research with George McBride founder of Clerkenwell Health
This week, James is joined by George McBride, co-founder and COO of Clerkenwell Health a psychedelic-specialty clinical research organisation and site network headquartered in London. George is a commercial barrister turned drug policy reform advocate and entrepreneur. He's played in a key role in the campaign to legalise medical cannabis in the UK at the NGO Volteface before founding Europe’s leading cannabis advisory firm, Hanway Associates and industry conference Cannabis Europa. Learn more about Clerkenwell Health: https://www.clerkenwellhealth.com/Apply to be a guest: www.thehealthtechpodcast.comSubscribe to Healthtech Pigeon 🐦:www.healthtechpigeon.comGet in touch with James: www.jamessomauroo.comLearn more about SomX for your healthtech company at somx.health